Traws Pharma, Inc.

Historical 13F Holders

Symbol: TRAW
CUSIP: 68232V884
All holders as of: Q2 2026
Type: Equity
Class: COM NEW

Reported Value, Excluding Options

Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 68232V884 since 12/18/2024, newest first.

Filer	% of Class	Shares	Form	Filed
Squadron Capital Management LLC 13G/A Amendment 4	0%	0	13G/A Amendment 4	8/14/2026 Event 6/30/2026
Squadron Master Fund LP	0%	0
Squadron Capital Management LLC	0%	0
Matthew Sesterhenn	0%	0
William Blank	0%	0
Ikarian Capital, LLC 13G/A Amendment 3	9.5%	1,555,423	13G/A Amendment 3	8/14/2026 Event 6/30/2026
Ikarian Capital, LLC	9.5%	1,555,423
Neil Shahrestani	9.5%	1,555,423
Sirenia Capital Management LP 13G	9.9%	6,565,474	13G	8/14/2026 Event 6/30/2026
Sirenia Capital Management LP	9.9%	6,565,474
Alex Silverstein	9.9%	6,565,474
Adage Capital Management, L.P. 13G/A Amendment 1	4.8%	730,000	13G/A Amendment 1	8/12/2026 Event 6/30/2026
Adage Capital Management, L.P.	4.8%	730,000
Robert Atchinson	4.8%	730,000
Phillip Gross	4.8%	730,000
Squadron Capital Management LLC 13G/A Amendment 3	6.4%	511,714	13G/A Amendment 3	5/15/2026 Event 3/31/2026
Squadron Master Fund LP	6.4%	511,714
Squadron Capital Management LLC	6.4%	511,714
Matthew Sesterhenn	6.4%	511,714
William Blank	6.4%	511,714
Perceptive Advisors LLC 13G/A Amendment 3	6.1%	979,815	13G/A Amendment 3	5/15/2026 Event 3/31/2026
Perceptive Advisors LLC	6.1%	979,815
Joseph Edelman	6.1%	979,815
Perceptive Life Sciences Master Fund, Ltd.	6.1%	979,815
Orbimed Advisors LLC 13D/A Amendment 3	11.9%	1,876,198	13D/A Amendment 3	5/5/2026 Event 4/16/2026
Orbimed Advisors LLC	11.9%	1,876,198
OrbiMed Capital GP VIII LLC	11.9%	1,876,198
Squadron Capital Management LLC 13G/A Amendment 2	8.9%	713,540	13G/A Amendment 2	2/17/2026 Event 12/31/2025
Squadron Master Fund LP	8.9%	713,540
Squadron Capital Management LLC	8.9%	713,540
Matthew Sesterhenn	8.9%	713,540
William Blank	8.9%	713,540
Ikarian Capital, LLC 13G/A Amendment 2	10.0%	812,524	13G/A Amendment 2	2/17/2026 Event 12/31/2025
Ikarian Capital, LLC	10.0%	812,524
Neil Shahrestani	10.0%	812,524
Adage Capital Management, L.P. 13G	9.1%	730,000	13G	2/12/2026 Event 12/31/2025
Adage Capital Management, L.P.	9.1%	730,000
Robert Atchinson	9.1%	730,000
Phillip Gross	9.1%	730,000
Ayrton Capital LLC 13G/A Amendment 1	4.3%	342,935	13G/A Amendment 1	2/11/2026 Event 12/31/2025
Ayrton Capital LLC	4.3%	342,935
Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B	4.3%	342,935
Waqas Khatri	4.3%	342,935
Chernett Jorey 13G	6.8%	543,268	13G	1/16/2026 Event 1/14/2026
Squadron Capital Management LLC 13G/A Amendment 1	8.4%	591,000	13G/A Amendment 1	11/14/2025 Event 9/30/2025
Squadron Master Fund LP	7.4%	523,359
Squadron Capital Management LLC	8.4%	591,000
Matthew Sesterhenn	8.4%	591,000
William Blank	8.4%	591,000
Perceptive Advisors LLC 13G/A Amendment 2	10.0%	886,887	13G/A Amendment 2	11/14/2025 Event 9/30/2025
Perceptive Advisors LLC	10.0%	886,887
Joseph Edelman	10.0%	886,887
Perceptive Life Sciences Master Fund, Ltd.	10.0%	886,887
Adage Capital Management, L.P. 13G/A Amendment 1	4.7%	330,000	13G/A Amendment 1	11/13/2025 Event 9/30/2025
Adage Capital Management, L.P.	4.7%	330,000
Robert Atchinson	4.7%	330,000
Phillip Gross	4.7%	330,000
Squadron Capital Management LLC 13G	6.0%	420,501	13G	9/19/2025 Event 9/12/2025
Squadron Master Fund LP	5.3%	372,374
Squadron Capital Management LLC	6.0%	420,501
Matthew Sesterhenn	6.0%	420,501
William Blank	6.0%	420,501
Ikarian Capital, LLC 13G/A Amendment 1	10.0%	589,502	13G/A Amendment 1	5/15/2025 Event 3/31/2025
Ikarian Capital, LLC	10.0%	589,502
Neil Shahrestani	10.0%	589,502
Perceptive Advisors LLC 13G/A Amendment 1	10.0%	545,197	13G/A Amendment 1	5/15/2025 Event 3/31/2025
Perceptive Advisors LLC	10.0%	545,197
Joseph Edelman	10.0%	545,197
Perceptive Life Sciences Master Fund, Ltd.	10.0%	545,197
Adage Capital Management, L.P. 13G	6.5%	330,000	13G	5/12/2025 Event 3/31/2025
Adage Capital Management, L.P.	6.5%	330,000
Robert Atchinson	6.5%	330,000
Phillip Gross	6.5%	330,000
Alyeska Investment Group, L.P. 13G	9.9%	302,252	13G	2/14/2025 Event 12/31/2024
Alyeska Investment Group, L.P.	9.9%	302,252
Alyeska Fund GP, LLC	9.9%	302,252
Anand Parekh	9.9%	302,252
Ikarian Capital, LLC 13G	10.0%	394,255	13G	2/14/2025 Event 12/31/2024
Ikarian Capital, LLC	10.0%	394,255
Neil Shahrestani	10.0%	394,255
Ayrton Capital LLC 13G	9.9%	403,650	13G	2/13/2025 Event 12/31/2024
Ayrton Capital LLC	9.9%	403,650
Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B	9.9%	403,650
Waqas Khatri	9.9%	403,650
Orbimed Advisors LLC 13D/A Amendment 2	19.9%	760,824	13D/A Amendment 2	1/29/2025 Event 12/31/2024
Orbimed Advisors LLC	19.9%	760,824
OrbiMed Capital GP VIII LLC	19.9%	760,824
Perceptive Advisors LLC 13G	9.9%	386,555	13G	1/8/2025 Event 12/31/2024
Perceptive Advisors LLC	9.9%	386,555
Joseph Edelman	9.9%	386,555
Perceptive Life Sciences Master Fund, Ltd	9.9%	386,555

13F Holders by Quarter

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q2	33	6.16 M	$5.19 M	$0
2026 Q1	28	3.62 M	$6.62 M	$0
2025 Q4	22	3.42 M	$3.86 M	$0
2025 Q3	18	1.30 M	$2.41 M	$0
2025 Q2	20	1.26 M	$1.87 M	$0
2025 Q1	19	1.73 M	$3.98 M	$0
2024 Q4	19	1.17 M	$10.2 M	$0
2024 Q3	12	646 k	$3.80 M	$0